561304-40-3 Usage
Appearance
White solid This chemical compound appears as a white solid, which is a common physical state for many organic compounds.
Molecular weight
358.28 g/mol The molecular weight of the compound is 358.28 grams per mole, which is the mass of one mole of the compound.
Derivative of benzoic acid
The compound is derived from benzoic acid, which is a simple carboxylic acid with potential applications in various fields.
Trifluoromethoxy substituent
The presence of a trifluoromethoxy group (-OCHF3) in the compound can influence its chemical properties, such as solubility and reactivity.
Building block in organic synthesis
The compound is often used as a building block in organic synthesis due to its unique structure, which can be further modified to create more complex molecules.
Pharmaceutical research
2-[(tert-butoxycarbonyl)amino]-3-(trifluoromethoxy)benzoic acid has potential pharmacological properties, making it a valuable compound in the development of new drugs.
Applications in drug development
The compound may be used in the development of new drugs, potentially leading to the creation of more effective treatments for various diseases and conditions.
Creation of novel materials and chemical processes
The compound's unique structure and properties may also contribute to the development of new materials and chemical processes, further expanding its potential applications.
Check Digit Verification of cas no
The CAS Registry Mumber 561304-40-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,6,1,3,0 and 4 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 561304-40:
(8*5)+(7*6)+(6*1)+(5*3)+(4*0)+(3*4)+(2*4)+(1*0)=123
123 % 10 = 3
So 561304-40-3 is a valid CAS Registry Number.
561304-40-3Relevant articles and documents
Bicyclic And Tricyclic Compounds As KAT II Inhibitors
-
Page/Page column 73, (2010/12/31)
Compounds of Formula X: wherein A, X, Y, Z, R5, R6a, and R6b are as defined herein, and pharmaceutically acceptable salts thereof, are described as useful for the treatment of cognitive deficits associated with schizophrenia and other neurodegenerative and/or neurological disorders in mammals, including humans.
Trifluoromethoxy substituted anilines: Metalation as the key step for structural elaboration
Leroux, Frederic,Castagnetti, Eva,Schlosser, Manfred
, p. 4693 - 4699 (2007/10/03)
Trifluoromethoxy-substituted anilines undergo hydrogen/lithium permutation ("metalation") with optional site selectivity depending on the N-protective group employed. N-tert-Butoxycarbonyl-2-and -4-(trifluoromethoxy)aniline react with tert-butyllithium at
